Cite
HARVARD Citation
Collins, L. et al. (2022). Early Experience Implementing Long-Acting Injectable Cabotegravir/Rilpivirine for Human Immunodeficiency Virus-1 Treatment at a Ryan White-Funded Clinic in the US South. Open forum infectious diseases. p. . [Online].